# OnCo record lurbinectedin-basket-sclc (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/lurbinectedin-basket-sclc/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "lurbinectedin-basket-sclc", "NCT02454972" ;
  schema:name "Lurbinectedin basket trial, small-cell lung cancer cohort"@en ;
  schema:alternateName "PM1183-B-005-14"@en, "Lurbinectedin SCLC basket"@en ;
  schema:description "A single-arm study of 105 patients that gave relapsed small-cell lung cancer its first new drug in decades, on a response rate rather than a survival benefit."@en ;
  schema:url <https://onco.cc/trials/lurbinectedin-basket-sclc/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02454972>, <https://doi.org/10.1016/S1470-2045(20)30068-1> ;
  onco:status "positive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/extensive-stage-sclc/>, <https://onco.cc/cancers/sclc/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/lurbinectedin/>, <https://onco.cc/drugs/topotecan/> ;
  onco:companies <https://onco.cc/companies/pharmamar/> ;
  onco:terms <https://onco.cc/terms/palliative-treatment/> ;
  onco:trials <https://onco.cc/trials/atlantis/>, <https://onco.cc/trials/imforte/> .